Private equity firm snaps up JHP for $195M

Contract manufacturer JHP Pharmaceuticals is now the property of private equity giant Warburg Pincus, as the company is spending $195 million to buy the CMO. JHP specializes in sterile injectables, and, with Warburg Pincus' backing, the company will be able to expand its generics manufacturing in the coming years, JHP CEO Stuart Hinchen said. More